Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07730723) titled 'The Effect of Nicorandil on Rheumatoid Arthritis Patients' on July 23.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Ain Shams University
Condition:
Rheumatoid Arthritis (RA)
Intervention:
Drug: Nicorandil Oral Tablet
Drug: Placebo
Recruitment Status: Not recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: August 2026
Target Sample Size: 70
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study/NCT07730723
Discl...